(19)
(11) EP 1 789 065 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
26.12.2012 Bulletin 2012/52

(45) Mention of the grant of the patent:
21.11.2012 Bulletin 2012/47

(21) Application number: 05778486.0

(22) Date of filing: 05.08.2005
(51) International Patent Classification (IPC): 
A61K 36/52(2006.01)
 A61P 31/02(2006.01)
(86) International application number:
PCT/US2005/027827
(87) International publication number:
WO 2006/017705 (16.02.2006 Gazette 2006/07)

(54)

PROCESS FOR PREPARING AN ANTI-MICROBIAL FRACTION FROM JUGLANS REGIA

VERFAHREN ZUR HERSTELLUNG VON EINER ANTI-MIKROBIELLE FRAKTION VON JUGLANS REGIA

PROCEDE DE PREPARATION D'UNE FRACTION ANTI-MICROBIENNE DE JUGLANS REGIA

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 06.08.2004 US 599541 P

(43) Date of publication of application:
30.05.2007 Bulletin 2007/22

(73) Proprietor: Bio-Quant, Inc.
San Diego, CA 92121 (US)

(72) Inventor:
  • DAMAJ, Bassam, B.
    San Diego, CA 92126 (US)

(74) Representative: Schiweck, Weinzierl & Koch 
European Patent Attorneys Landsberger Straße 98
80339 München
80339 München (DE)


(56) References cited: : 
WO-A2-01/34170
US-A- 5 882 648
 US-A- 5 137 717
US-B1- 6 395 261
   
  • FUKUDA T ET AL: "Antioxidative polyphenols from walnuts (Juglans regia L.)" PHYTOCHEMISTRY, PERGAMON PRESS, GB LNKD- DOI:10.1016/S0031-9422(03)00333-9, vol. 63, no. 7, 1 August 2003 (2003-08-01) , pages 795-801, XP004439106 ISSN: 0031-9422
  • HAQUE R ET AL: "Aqueous extract of walnut (Juglans regia L.) protects mice against cyclophosphamide-induced biochemical toxicity." HUMAN & EXPERIMENTAL TOXICOLOGY SEP 2003 LNKD- PUBMED:14580007, vol. 22, no. 9, September 2003 (2003-09), pages 473-480, XP9135452 ISSN: 0960-3271
  • LAGRANGE E: "[Bactericidal action of extract of the leaves of the walnut, Juglans regia L..]" COMPTES RENDUS DES SÉANCES DE LA SOCIÉTÉ DE BIOLOGIE ET DE SES FILIALES DEC 1954 LNKD- PUBMED:14379599, vol. 148, no. 23-24, December 1954 (1954-12), pages 2097-2098, XP9135459 ISSN: 0037-9026
  • ALKHAWAJAH A M: "Studies on the antimicrobial activity of juglans regia." THE AMERICAN JOURNAL OF CHINESE MEDICINE 1997 LNKD- PUBMED:9288364, vol. 25, no. 2, 1997, pages 175-180, XP9135453 ISSN: 0192-415X
  • MEHRABIAN S ET AL: "Antimicrobial effects of three plants (rubia tinctorum, carthamus tinctorius and juglans regia) on some airborne microorganisms" AEROBIOLOGIA 2000 NL LNKD- DOI:10.1023/A:1026571914665, vol. 16, no. 3-4, 2000, pages 455-458, XP002589444 ISSN: 0393-5965
  • KAUR KAMALJIT ET AL: "Studies on correlation of antimutagenic and antiproliferative activities of Juglans regia L." JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY, vol. 22, no. 1, 2003, pages 59-67, XP9135457 ISSN: 0731-8898
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).